2-176093057-GGGCGGCGGCGGC-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP3BS1_SupportingBS2
The NM_000523.4(HOXD13):βc.171_182delβ(p.Ala68_Ala71del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000158 in 1,369,924 control chromosomes in the GnomAD database, including 9 homozygotes. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.00021 ( 0 hom., cov: 33)
Exomes π: 0.00015 ( 9 hom. )
Consequence
HOXD13
NM_000523.4 inframe_deletion
NM_000523.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.39
Genes affected
HOXD13 (HGNC:5136): (homeobox D13) This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXD genes located in a cluster on chromosome 2. Deletions that remove the entire HOXD gene cluster or the 5' end of this cluster have been associated with severe limb and genital abnormalities. Mutations in this particular gene cause synpolydactyly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_000523.4
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000205 (31/150896) while in subpopulation EAS AF= 0.00508 (26/5114). AF 95% confidence interval is 0.00356. There are 0 homozygotes in gnomad4. There are 16 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 9 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HOXD13 | NM_000523.4 | c.171_182del | p.Ala68_Ala71del | inframe_deletion | 1/2 | ENST00000392539.4 | |
HOXD13 | XM_011511068.3 | c.725-1419_725-1408del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HOXD13 | ENST00000392539.4 | c.171_182del | p.Ala68_Ala71del | inframe_deletion | 1/2 | 1 | NM_000523.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000206 AC: 31AN: 150788Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
31
AN:
150788
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00158 AC: 34AN: 21526Hom.: 5 AF XY: 0.00126 AC XY: 17AN XY: 13458
GnomAD3 exomes
AF:
AC:
34
AN:
21526
Hom.:
AF XY:
AC XY:
17
AN XY:
13458
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000152 AC: 185AN: 1219028Hom.: 9 AF XY: 0.000139 AC XY: 83AN XY: 595810
GnomAD4 exome
AF:
AC:
185
AN:
1219028
Hom.:
AF XY:
AC XY:
83
AN XY:
595810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000205 AC: 31AN: 150896Hom.: 0 Cov.: 33 AF XY: 0.000217 AC XY: 16AN XY: 73668
GnomAD4 genome
AF:
AC:
31
AN:
150896
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
73668
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 09, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant is also known as c.171_182delGGCGGCGGCGGC p.56_60delAAAA. This variant has been observed in individual(s) with clinical features of synpolydactyly and/or polydactyly (PMID: 18399101, 33533119). It has also been observed to segregate with disease in related individuals. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant, c.171_182del, results in the deletion of 4 amino acid(s) of the HOXD13 protein (p.Ala68_Ala71del), but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at